1492 Capital Management’s Omnicell OMCL Stock Holding History

1492 Capital Management’s Portfolio OMCL Stock Details OMCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-7,511	Closed	-$854K	–	119
2022 Q2	$854K	Buy	+7,511	New	+$862K	0.56%	63
2019 Q2	–	Sell	-14,033	Closed	-$1.13M	–	95
2019 Q1	$1.13M	Sell	14,033 -1,390	-9%	-$104K	0.96%	33
2018 Q4	$945K	Sell	15,423 -1,127	-7%	-$76.3K	0.85%	37
2018 Q3	$1.19M	Sell	16,550 -70	-0.4%	-$4.41K	0.77%	46
2018 Q2	$872K	Sell	16,620 -258	-2%	-$12.1K	0.62%	52
2018 Q1	$733K	Hold	16,878	–	–	0.56%	52
2017 Q4	$819K	Sell	16,878 -134	-0.8%	-$6.76K	0.64%	48
2017 Q3	$868K	Sell	17,012 -41	-0.2%	-$1.96K	0.77%	42
2017 Q2	$735K	Sell	17,053 -276	-2%	-$11.5K	0.65%	47
2017 Q1	$704K	Buy	+17,329	New	+$639K	0.55%	46

Other funds holding OMCL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

1492 Capital Management's OMCL Position: Q3 2022 in Review

1492 Capital Management sold out of Omnicell (OMCL) in Q3 2022, closing a stake of 7,511 shares — an estimated $854K sold.

1492 Capital Management first reported a position in OMCL in Q1 2017 and held it in 10 quarters. The position peaked at $1.19M in Q3 2018. 374 funds tracked by Wall St. Rank hold OMCL as of Q3 2022.

1492 Capital Management reported no remaining Omnicell position as of Q3 2022 after selling out during the quarter.
1492 Capital Management sold 7,511 Omnicell shares in Q3 2022, an estimated $854K.
1492 Capital Management first reported a position in Omnicell in Q1 2017 and held it in 10 quarters.
1492 Capital Management's Omnicell position peaked at $1.19M in Q3 2018.
374 funds tracked by Wall St. Rank held Omnicell as of Q3 2022.

Based on 1492 Capital Management's 13F filing for Q3 2022, filed 10 Nov 2022.